Evidence map›Paper›PMID 41522726›Full record

ArticleBioMed research international2026

Inflammatory Bowel Disease Outcomes in Northern Iran: A Retrospective Cohort Study of Remission, Complications, and Treatment Strategies.

Poria Hoseinialiabadi, Iradj Maleki, Hafez Fakheri, Mahboobe Ebrahimi, Elham Yousefi Abdolmaleki, Tarang Taghvaei, Hajar Shokri-Afra

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BioMed research international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Poria HoseinialiabadiGut and Liver Research Center, Non-Communicable Disease Research Institute, Mazandaran University of Medical Sciences, Sari, Iran, mazums.ac.ir.ORCID https://orcid.org/0000-0002-3001-2948
Iradj MalekiGut and Liver Research Center, Non-Communicable Disease Research Institute, Mazandaran University of Medical Sciences, Sari, Iran, mazums.ac.ir.ORCID https://orcid.org/0000-0003-2395-8118
Hafez FakheriGut and Liver Research Center, Non-Communicable Disease Research Institute, Mazandaran University of Medical Sciences, Sari, Iran, mazums.ac.ir.ORCID https://orcid.org/0000-0002-0579-6111
Mahboobe EbrahimiGut and Liver Research Center, Non-Communicable Disease Research Institute, Mazandaran University of Medical Sciences, Sari, Iran, mazums.ac.ir.ORCID https://orcid.org/0000-0001-5473-282X
Elham Yousefi AbdolmalekiGut and Liver Research Center, Non-Communicable Disease Research Institute, Mazandaran University of Medical Sciences, Sari, Iran, mazums.ac.ir.ORCID https://orcid.org/0000-0002-6493-1512
Tarang TaghvaeiGut and Liver Research Center, Non-Communicable Disease Research Institute, Mazandaran University of Medical Sciences, Sari, Iran, mazums.ac.ir.ORCID https://orcid.org/0000-0003-4360-7323
Hajar Shokri-AfraGut and Liver Research Center, Non-Communicable Disease Research Institute, Mazandaran University of Medical Sciences, Sari, Iran, mazums.ac.ir.ORCID https://orcid.org/0000-0001-9558-7104

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Inflammatory bowel disease (IBD), encompassing Crohn's disease (CD) and ulcerative colitis (UC), is a chronic inflammatory condition affecting the gastrointestinal tract. While significant progress has been made in managing IBD, the long-term outcomes remain heterogeneous, prompting this cohort study. Methods: A retrospective analysis was performed on patients with IBD registered between 2000 and 2023. Clinical data, including demographics, disease activity, remission rates, therapeutic approaches, and complications, were collected. Results: Among 600 enrolled patients, 72.8% were diagnosed with UC. Both patients with UC and those with CD showed improvements in endoscopic severity by the end of follow-up ( Conclusion: The study showed significant clinical improvement, yet many patients, particularly those with severe initial disease, had incomplete remission and frequent relapses, necessitating more effective long-term management strategies. The distinction between CD and UC highlights the need for specialized treatments.

Indexed as

Colitis, UlcerativeCrohn DiseaseInflammatory Bowel DiseasesAdolescentAdultDisease ProgressionFemaleHumansIranMaleMiddle AgedRecurrenceRemission InductionRetrospective StudiesTreatment OutcomeYoung AdultCrohn diseaseinflammatory bowel diseaserecurrenceremissionulcerative colitis

Identifiers

PMID41522726
PMCPMC12780852

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.